Dear Sir, In a recent publication Dornan et al. [1] reported an association between HLA-DR4 and retinopathy in Type I (insulin-dependent) diabetic patients and concluded that genetically determined factors appeared to influence susceptibility to retinopathy. We have also examined the relationship between HLA and retinopathy in a smaller series of patients with Type 1 diabetes with onset before the age of 40years and duration > 10years. Patients were divided into three groups; those with no retinal changes, those with background retinopathy and those with severe retinopathy (proliferative changes or vascular changes requiring laser therapy). HLA antigens, properdin factor B(Bf) and complement C4 allotypes were determined in these patients. Table 1 shows the frequencies of HLA-B8, B15, DR3, DR4 and the complement variant C4B2.9 in the three patient groups examined. Although B 15 and DR4 are more frequent in patients with severe retinopathy, the differences were not statistically significant. The rare factor B allele BfFI was equally prevalent among the patients with and without retinopathy. On the other hand, the C4B allele C4B2.9 was present in 28% with severe retinopathy and only in 10% of patients with no retinopathy (NS). This variant is nearly always found on a DR4 haplotype and is also associated with rheumatoid arthritis. 2 (13%) 5 (42%0) 9 (41%) n= 11 n = 10 n = 17 DR3 7 (64%) 8 (80%) 10 (59%) DR4 a 4 (36%) 5 (50%) 12 (71%0) n = 10 n= 11 n = 18 C4B2.9 b 1 (10%) 2 (18%) 5 (28%) a Fisher's exact probability for this distribution p = 0.22; b Fisher's exact probability for this distribution p = 0.61 221 Dornan et al. [1] suggested that the association between retinopathy and DR4 may be related to anti-insulin antibodies. In our data, insulin antibodies were more frequent in those with severe retinopathy (82%) compared to those with no retinopathy or background retinopathy (54%), but there was no difference in the prevalence of insulin antibodies in those with and without HLA-DR4. By contrast, insulin antibodies were less frequent in patients positive for HLA-DR3 (50%) than those without this antigen (83%).
Based upon glycosylated haemoglobin estimations, there was no significant difference in diabetic control in patients with DR4 compared with those without DR4 (mean value 13.5% versus 12.2%).
Studies of HLA and microvascular complications in Type 1 diabetes have produced conflicting results [2] . In our patients, as in other studies, the major risk factor influencing the prevalence of retinopathy is the duration of diabetes. Hence any additional genetic influence is likely to be difficult to detect. Bodansky and Wolf [3] emphasized the multiple factors contributing to retinopathy and Barbosa and Ramsay [4] have summarised some of the logistic requirements for future population studies on this question. 
